Thrivent Financial for Lutherans Has $5.65 Million Stock Holdings in Centene Co. (NYSE:CNC)

Thrivent Financial for Lutherans lifted its position in shares of Centene Co. (NYSE:CNC) by 9.2% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 74,998 shares of the company’s stock after buying an additional 6,337 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Centene were worth $5,645,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the business. Claro Advisors LLC acquired a new position in shares of Centene during the 3rd quarter worth approximately $332,000. Mutual of America Capital Management LLC grew its position in Centene by 1.5% during the third quarter. Mutual of America Capital Management LLC now owns 98,022 shares of the company’s stock worth $7,379,000 after buying an additional 1,445 shares in the last quarter. Seizert Capital Partners LLC increased its stake in Centene by 6.2% during the 3rd quarter. Seizert Capital Partners LLC now owns 112,141 shares of the company’s stock worth $8,442,000 after acquiring an additional 6,564 shares during the period. Natixis Advisors LLC lifted its position in shares of Centene by 7.8% during the 3rd quarter. Natixis Advisors LLC now owns 414,960 shares of the company’s stock valued at $31,238,000 after acquiring an additional 30,141 shares during the period. Finally, Empirical Finance LLC grew its holdings in shares of Centene by 2.0% during the 3rd quarter. Empirical Finance LLC now owns 18,805 shares of the company’s stock worth $1,416,000 after purchasing an additional 368 shares in the last quarter. 93.63% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, CEO Sarah London acquired 4,117 shares of Centene stock in a transaction dated Friday, November 8th. The shares were bought at an average cost of $60.80 per share, with a total value of $250,313.60. Following the purchase, the chief executive officer now owns 667,229 shares in the company, valued at $40,567,523.20. This trade represents a 0.62 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Andrew Lynn Asher bought 17,200 shares of the stock in a transaction that occurred on Wednesday, November 13th. The shares were purchased at an average cost of $58.14 per share, with a total value of $1,000,008.00. Following the purchase, the chief financial officer now directly owns 486,847 shares of the company’s stock, valued at $28,305,284.58. The trade was a 3.66 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 0.33% of the company’s stock.

Centene Price Performance

CNC stock opened at $60.37 on Friday. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.10 and a current ratio of 1.10. Centene Co. has a 52-week low of $57.20 and a 52-week high of $81.42. The company has a market capitalization of $30.48 billion, a P/E ratio of 10.48, a PEG ratio of 0.83 and a beta of 0.49. The company has a fifty day moving average price of $66.68 and a 200-day moving average price of $70.46.

Analyst Ratings Changes

Several research firms recently weighed in on CNC. StockNews.com cut shares of Centene from a “strong-buy” rating to a “buy” rating in a research report on Monday, October 28th. Wells Fargo & Company reduced their price target on shares of Centene from $91.00 to $90.00 and set an “overweight” rating on the stock in a research report on Monday, November 4th. Robert W. Baird cut their target price on Centene from $83.00 to $66.00 and set a “neutral” rating for the company in a research note on Friday, October 25th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $90.00 price target on shares of Centene in a research note on Tuesday, October 1st. Finally, Sanford C. Bernstein reduced their price objective on Centene from $96.00 to $88.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 30th. Seven investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $83.92.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.